Recent News

• 03.10.2025 - Leerink Partners Global Healthcare Conference
• 03.10.2025 - Leerink Partners Global Healthcare Conference
• 03.05.2025 - TD Cowen 45th Annual Healthcare Conference
• 03.05.2025 - TD Cowen 45th Annual Healthcare Conference
• 02.26.2025 - Stoke Therapeutics to Present at Upcoming Investor Conferences in March
• 02.26.2025 - Stoke Therapeutics to Present at Upcoming Investor Conferences in March
• 02.18.2025 - Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments
• 02.18.2025 - Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments
• 01.15.2025 - 43rd Annual J.P. Morgan Healthcare Conference
• 01.15.2025 - 43rd Annual J.P. Morgan Healthcare Conference

Recent Filings

• 02.18.2025 - 8-K Current report
• 02.18.2025 - EX-99.1 EX-99.1
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.03.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors